Allogeneic cell therapy product

· Pluristem Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic cell therapy product, covering 2019-02-12 to 2019-02-12. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC) [Phase 2]